Astellas Pharma (United States)
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Astellas Pharma (United States), United States, covering academic research published from 2005 to 2024. Read More.
Open Access Percentage
49%
Total
Publications
1.7K
Total Open
Publications
827
Total
Citations
53K
Open Access
Percentage
49%
Total
Publications
1.7K
Total Open
Publications
827
Total
Citations
53K
Breakdown
Publisher Open
17%
Both
27%
Other Platform Open
4%
Closed
52%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 31%
228
Hybrid 46%
344
No Guarantees 23%
173
Other Platform Open
Domain 85%
462
Institution 15%
81
Other Internet 12%
65
Public 2%
13
Preprint 0%
0
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 463 |
DOI | Other Internet | 63 |
Europe PMC | Domain | 24 |
Digital Access to Libraries | Institution | 15 |
DANS - Data Archiving and Networked Services | Institution | 15 |
Figshare | Public | 13 |
University of Southern Denmark - University of Southern Denmark Research Portal | Institution | 5 |
Washington University School of Medicine - Digital Commons@Becker | Institution | 4 |
KU Leuven - Lirias | Institution | 4 |
University of Michigan - Deep Blue | Institution | 3 |